Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

Go back to Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.21 --0 (-0%)
Previous Close $10.21    52 Week High $2.18 
Open $10.21    52 Week Low $0.30 
Day High $10.21    P/E N/A 
Day Low $10.21    EPS $-3.32 
Volume 2,404       

TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.21 --0 (-0%)
Previous Close $10.21    52 Week High $2.18 
Open $10.21    52 Week Low $0.30 
Day High $10.21    P/E N/A 
Day Low $10.21    EPS $-3.32 
Volume 2,404